trial summary · NCT06801223
A Study to Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection
A Multicenter, Open-label, Phase 1b Study to Assess the Pharmacokinetics, Safety, and Tolerability of Sulbactam-Durlobactam in Hospitalized Pediatric Patients From Birth to <18 Years Who Are Receiving Systemic Antibiotic Therapy for Suspected or Confirmed Acinetobacter Baumannii-calcoaceticus Complex Infection
Trial record from the TrialBase DB dataset, status RECRUITING, condition Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC), sponsored by Innoviva Specialty Therapeutics. Facts below are exported values from the current release, not inferred or edited prose.
Summary
The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.
The goal of this clinical trial is to investigate the use of Sulbactam-Durlobactam (SUL-DUR) in pediatric patients and is being conducted to collect pharmacokinetic (PK) and safety data to enable the identification of appropriate pediatric dosing regimens for patients with Acinetobacter baumannii-calcoaceticus complex (ABC) infections
Source record: https://clinicaltrials.gov/study/NCT06801223
Facts
| registry id | NCT06801223 |
|---|---|
| primary registry | clinicaltrials-gov |
| recruitment status | RECRUITING |
| phase | PHASE1 |
| study type | INTERVENTIONAL |
| lead condition | Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC) |
| sponsor | Innoviva Specialty Therapeutics |
| sponsor class | INDUSTRY |
| enrollment | 48 |
| start date | 2026-12-30 |
| primary completion | 2028-05-05 |
| completion | 2028-05-20 |
| results posted | not reported |
Conditions
- Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Interventions
- Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours)
- Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 8 hours)
- Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 8 hours)
- Sulbactam 20mg/kg-Durlobactam 20mg/kg (Every 12 hours)
Countries
- United States
Intervention types: DRUG
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access; credited toward the licence.